Prospects for Chemoprevention of Cancers of the Cervix, Endometrium and Ovary: Surrogate Endpoints and Design of Clinical Trials. Conference proceedings. Oxnard, California, February 1-5, 1995.
D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D018890:Chemoprevention; D002986:Clinical Trials as Topic / Q000592:standards*; D016889:Endometrial Neoplasms / Q000378:metabolism / Q000517:prevention & control*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000517:prevention & control*; D002583:Uterine Cervical Neoplasms / Q000378:metabolism / Q000517:prevention & control*
D016588:Anticarcinogenic Agents; D014408:Biomarkers, Tumor